Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00598117 · ClinicalTrials.gov registry record

Quality Of Life Outcomes Following Treatment for Esophageal Cancer

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
409
Enrollment target

NCT00598117: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00598117 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 409 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00598117 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
409 participants
Enrollment target

Study Summary

The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will provide important information that can be used to develop programs to improve the quality of life of patients with esophageal cancer.

Interventions

  • BEHAVIORAL Questionnaires

Trial Details

FieldValue
Enrollment Target 409 participants
Start Date 2003-08
Est. Completion 2013-06

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00598117

The ClinicalTrials.gov registry entry for NCT00598117 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 409 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.

NCT00598117 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00598117 about?

NCT00598117 is a clinical study titled "Quality Of Life Outcomes Following Treatment for Esophageal Cancer". The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will prov...

What is the current status of trial NCT00598117?

This trial is currently completed. The enrollment target is 409 participants. The study started on 2003-08. Estimated completion is 2013-06.

What interventions are being tested in trial NCT00598117?

The interventions under investigation include: Questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT00598117?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.